AstraZeneca becomes latest drugmaker to strike deal with Trump. Its stock is climbing after hours.
AstraZeneca announced a deal with U.S. President Donald Trump that’s focused on lowering drug prices, in a move that would see the British drugmaker follow in the footsteps of Pfizer.
